A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer
Open Access
- 28 August 2008
- journal article
- Published by Springer Nature in Breast Cancer Research
- Vol. 10 (4), R73
- https://doi.org/10.1186/bcr2138
Abstract
Introduction: Patients with primary operable oestrogen receptor (ER) negative (-) breast cancer account for about 30% of all cases and generally have a worse prognosis than ER-positive (+) patients. Nevertheless, a significant proportion of ER- cases have favourable outcomes and could potentially benefit from a less aggressive course of therapy. However, identification of such patients with a good prognosis remains difficult and at present is only possible through examining histopathological factors. Methods: Building on a previously identified seven-gene prognostic immune response module for ER- breast cancer, we developed a novel statistical tool based on Mixture Discriminant Analysis in order to build a classifier that could accurately identify ER- patients with a good prognosis. Results: We report the construction of a seven-gene expression classifier that accurately predicts, across a training cohort of 183 ER- tumours and six independent test cohorts (a total of 469 ER- tumours), ER- patients of good prognosis (in test sets, average predictive value = 94% [range 85 to 100%], average hazard ratio = 0.15 [range 0.07 to 0.36] p < 0.000001) independently of lymph node status and treatment. Conclusions: This seven-gene classifier could be used in a polymerase chain reaction-based clinical assay to identify ER- patients with a good prognosis, who may therefore benefit from less aggressive treatment regimens.Keywords
This publication has 28 references indexed in Scilit:
- Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular SubtypesClinical Cancer Research, 2008
- The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast CancerCancer Research, 2008
- Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomasBreast Cancer Research, 2007
- An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancerGenome Biology, 2007
- EGFR associated expression profiles vary with breast tumor subtypeBMC Genomics, 2007
- Prognostic markers in triple‐negative breast cancerCancer, 2006
- Genomic and transcriptional aberrations linked to breast cancer pathophysiologiesCancer Cell, 2006
- An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survivalProceedings of the National Academy of Sciences, 2005
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- Model-Based Clustering, Discriminant Analysis, and Density EstimationJournal of the American Statistical Association, 2002